Wednesday, July 8, 2026

biotech · Presbyopia · Eye Diseases · LENZ

LENZ Therapeutics

LENZ Therapeutics patent portfolio — 20 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

San Diego, USA HQ
176 Employees
Public company Type
LENZ · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Employees
176
Programs
5
Drugs
6
Patents
20
Intelligence · Patents

LENZ Therapeutics patents

20 pharmaceutical patents indexed for LENZ Therapeutics. 0 expire within 24 months.

LENZ Therapeutics has 20 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12414942

    Compositions, methods, and systems for treating presbyopia

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12180206

    Aceclidine derivatives, compositions thereof and methods of use thereof

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12128036

    Compositions and methods for storage stable ophthalmic drugs

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11648247

    Compositions and methods for the treatment of presbyopia

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11344538

    Methods for the treatment of myopia

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11273150

    Compositions and methods for the treatment of presbyopia

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11214569

    Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11179327

    Compositions and methods for the treatment of presbyopia

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 11179328

    Compositions and methods for the treatment of presbyopia

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 10827969

    Breath test device and method

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 10456340

    Liquid-impregnated nonwoven fabric which contains zinc oxide-containing cellulose fibers

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 10093790

    Three-dimensional cellulose molded body, method for the production thereof and use of the same

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 9873964

    Dispersible non-woven fabrics

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 8822698

    Aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the Met family

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 8633120

    Lyocell fiber

    Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 8622920

    Breath test device and method

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 8512258

    Breath test device and method

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 8469899

    Management of gastro-intestinal disorders

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7867171

    Management of gastro-intestinal disorders

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 6238605

    Low-fibrillation moulded bodies

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does LENZ Therapeutics have?

20 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do LENZ Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.